Skip to main content

German Cancer Research Center To Use Febit Analyzer for miRNA Studies

NEW YORK (GenomeWeb News) – The German Cancer Research Center, or DFKZ, will use Febit’s Geniom RT Analyzer for its research into the roles of microRNAs in cancer, Febit said today.
 
Heidelberg-based DFKZ will use the Geniom RT analyzer for microarray analysis of miRNA profiles in biological samples.
 
Febit said the system can be used to fragment and sort large genomes into smaller fractions, which may then be used as samples in mutation analysis and high-throughput sequencing studies.
 
Febit also said that the analyzer has “a high degree of automation,” it is user-friendly, and it combines hybridization, staining, washing, shaking, and detection into one instrument.
 
Financial terms of the agreement were not released.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.